Log in
Enquire now
Pelage Pharma

Pelage Pharma

Pelage is a clinical-stage regenerative medicine company developing novel treatments for hair loss, including androgenetic alopecia. Based on discoveries in stem cell biology made by Pelage's scientific co-founders, the company's novel approach is designed to reactivate dormant hair follicle stem cells and restore the body's ability to grow hair.

OverviewStructured DataIssuesContributors

Contents

pelagepharma.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Health technology
Health technology
Manufacturing
Manufacturing
Location
Los Angeles County, California
Los Angeles County, California
B2X
B2C
B2C
CEO
‌
Daniel Gil
Number of Employees (Ranges)
1 – 10
Email Address
info@pelagepharma.com
media@pelagepharma.com
Investors
Google Ventures
Google Ventures
ARCH Venture Partners
ARCH Venture Partners
Main Street Advisors
Main Street Advisors
‌
Visionary Ventures
‌
Main Street Advisors
‌
YK Bioventures
Visionary Ventures
Visionary Ventures
Total Funding Amount (USD)
134,000,000
Latest Funding Round Date
October 15, 2025
Latest Funding Type
Series B
Series B
CMO
‌
Christina Weng MD

Other attributes

Latest Funding Round Amount (USD)
120,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Pelage Pharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.